Showcases Stock ranks Forex

Elanco Animal Health Inc (ELAN)
14.35  -0.4 (-2.71%) 04-12 16:00
Open: 14.66 Pre. Close: 14.75
High: 14.74 Low: 14.23
Volume: 4,395,761 Market Cap: 7,074(M)
Stock Technical Analysis
Target: Six months: 18.43
One year: 19.54
Support: Support1: 14.23
Support2: 11.84
Resistance: Resistance1: 15.77
Resistance2: 16.73
Pivot: 15.51
Moving Averages: MA(5): 14.92
MA(20): 15.62
MA(100): 14.87
MA(250): 12.18
MACD: MACD(12,26): -0.29
Signal(12,26,9): -0.13
%K %D: %K(14,3): 6.67
%D(3): 8.43
RSI: RSI(14): 27.99
52-Week: High: 16.88
Low: 7.88
Change(%): 54.6
Average Vol(K): 3-Month: 4096
10-Days: 4130
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 14.782 - 14.864 14.864 - 14.93
Low: 13.979 - 14.094 14.094 - 14.187
Close: 14.181 - 14.351 14.351 - 14.49
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.

[ ELAN ] has closed below the lower bollinger band by 4.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Stock chart
Stock News
Sat, 13 Apr 2024
Why Elanco Animal Health Incorporated (ELAN) Could Beat Earnings Estimates Again - Yahoo Movies UK

Sat, 13 Apr 2024
HBK Sorce Advisory LLC Makes New $169000 Investment in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Fri, 12 Apr 2024
Sapient Capital LLC Takes $2.05 Million Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Wed, 10 Apr 2024
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Wed, 10 Apr 2024
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Tue, 09 Apr 2024
Insufficient Growth At Elanco Animal Health Incorporated (NYSE:ELAN) Hampers Share Price - Yahoo Movies Canada

Financial Analysis
Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Underperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty & Generic
Shares Out. (M) 492.97
Shares Float (M) 490.57
% Held by Insiders 0.65
% Held by Institutions 99.20
Shares Short (K) 12980
Shares Short Prior Month (K) 11970
Stock Financials
EPS -2.500
Book Value (p.s.) 12.630
Profit Margin -27.87
Operating Margin 1.64
Return on Assets (ttm) 1.4
Return on Equity (ttm) -18.2
Qtrly Rev. Growth 5.1
Gross Profit (p.s.)
Sales Per Share 8.966
EBITDA (p.s.) 1.974
Qtrly Earnings Growth
Operating Cash Flow (M) 271.00
Levered Free Cash Flow (M) 388.00
Stock Valuation
PE Ratio -5.74
PEG Ratio 1.90
Price to Book value 1.14
Price to Sales 1.60
Price to Cash Flow 26.10
Stock Dividends
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android